Vivo released the Vivo X Fold 5 in the Indian market two months ago. It is the brand’s second foldable phone in India, after the Vivo X Fold 3. The Vivo X5 Fold might not have the latest and greatest ...

The Galaxy Z Tri-Fold introduces an innovative trifold design that incorporates two hinges to create a three-panel display. This design allows the device to fold into a compact form for easy ...

Xiaomi hasn’t said much about its foldable roadmap since launching the Mix Fold 4 in 2024, but a fresh leak suggests the company could be preparing for an unexpected shift. According to XiaomiTime, a ...

Launched in 2019, the initiative aims to provide universal health coverage to the citizens of India.

The Samsung Galaxy Z Fold 8 is poised to make a significant impact in the foldable smartphone market. With advancements in display technology, performance, and usability, this device aims to overcome ...

This article is brought to you by our exclusive subscriber partnership with our sister title USA Today, and has been written by our American colleagues. It does not necessarily reflect the view of The ...

The real estate landscape along the Yamuna Expressway is rapidly changing. Prime Minister Narendra Modi on 25th November 2021 laid the foundation stone of the Noida International Airport (Jewar ...

As The Walking Dead: Daryl Dixon prepares to wrap up its penultimate season, AMC teased fans at New York Comic Con with what’s to come. During the show’s Season 3 panel, the audience was treated to a ...

The Supreme Court on Wednesday allowed President Donald Trump to terminate for now, without cause, President Biden's appointees to the Consumer Product Safety Commission. The decision further limits a ...

Samsung’s upcoming tri-fold smartphone has been in the works for what feels like ages, but its long-awaited launch might be just around the corner. The phone — possibly called the Galaxy Z TriFold — ...

Amicus Therapeutics, Inc. (NASDAQ:FOLD) is one of the best biotech stocks with high potential. On September 18, Needham analyst Gil Blum upgraded the rating on Amicus Therapeutics, Inc. (NASDAQ:FOLD) ...